Case
Study#4
1
2
3
4
5
6
7
8 9
10 11
12 13
14 15
16 17
Drug Susceptibility Testing
- Primary
drugs (for M. tuberculosis)
- Bactec
system
- Rifampin,
Isoniazid, Streptomycin, Ethambutol, Pyrazinamide
- Secondary
drugs
 |
 |
 |
| Growth
control |
3+
|
 |
| Control
(1/100 dilution) |
8
col
|
| Clarithromycin
15ug/ml |
0
|
| Doxycycline
6ug/ml |
3+
|
| Trimeth/Sulfa30ug/ml |
3+
|
| Cefoxitin
30ug/ml |
13
col
|
| Tobramycin
8ug/ml |
3+
|
| Amikacin
6ug/ml |
3+
|
| Amikacin
30ug/ml |
0
|
| Ciprofloxacin
8ug/ml |
3+
|
Disposition
- Final
Interpretation
- Mycobacterium
chelonae complex with susceptibility pattern consistent
with Mycobacterium abscessus
|